Summary
Researchers evaluated the analgesic efficacy of native Himalayan shilajit as a complementary therapy in patients with myofascial pain syndrome. The study involved a group of 30 participants who received shilajit in addition to standard treatment. After 4 weeks, a significant reduction in pain intensity was observed, with 70% of participants reporting relief. Shilajit, rich in fulvic acids and minerals, may act on modulating inflammation and improving blood circulation, important factors in myofascial pain. Although the results are promising, the study has limitations, such as the small number of participants and the lack of a control group. Further research is needed to confirm these findings and understand the mechanisms involved.
Key points
- 70% of participants reported significant pain reduction after 4 weeks of shilajit treatment.
- Shilajit contains fulvic acids, which may help modulate inflammation.
- The study had a small number of participants (30), limiting the generalizability of the results.
- The lack of a control group makes it difficult to attribute the effects exclusively to shilajit.
- Improved blood circulation may be a key mechanism for pain relief.
✦ For you
If you suffer from muscle pain or tension, consider including shilajit in your routine, always observing how your body reacts. Additionally, maintain good hydration and practice regular stretching. If pain persists, seek a qualified healthcare professional.
For practitionersExpand
When considering the use of shilajit (Śilājit) in patients with myofascial pain syndrome, observe individual response and the possibility of interaction with other treatments. Dosage and administration form should be adjusted according to the patient's needs, always considering the origin and quality of the shilajit used.